Separate names with a comma.
Mongersen drug was bought by Celgene for $710 million four years ago. Yesterday, Celgene announced that Mongersen had failed and it is going to...
Celgene to stop the two trials for Crohn's disease and will not start the third trial as per the recommendation from Data Monitoring Committee....
Celgene to receive royalties on global net sales in the pulmonary hypertension field.
Celgene presenting data for Abraxane at ESMO 2017. [IMG]
Celgene forced to pause 5 trials using AstraZeneca’s Imfinzi and full hold on one trial.
Have an interview coming up at the Summit site, any advice would be greatly appreciated.
